marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Onconova Therapeutics Financial Ratios 2011-2024 | ONTX
Annual Financial Ratios Onconova Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.1 | -0.8 | -2.7 | -4.6 | -0.2 | -0.5 | -0.5 | -0.6 | -0.6 | -1.3 | -2.6 | - | - |
P/S |
92.9 | 67.5 | 189.9 | 504.8 | 2.4 | 8.2 | 16.4 | 2.0 | 1.3 | 104.2 | 33.8 | - | - |
EPS |
-0.9 | -0.9 | -1.0 | -2.2 | -1.5 | -5.0 | -2.7 | -4.4 | -1.1 | -2.9 | -6.1 | -15.3 | -14.2 |
EV (Enterprise Value) |
12.4 M | -12.4 M | -2.79 M | 111 M | -5.45 M | 5.63 M | 24.7 M | 7.86 M | 7.13 M | 63.5 M | 125 M | -40.7 M | 140 M |
EBITDA per Share |
-0.97 | -0.94 | -0.98 | -2.15 | -22.6 | -84.5 | -641 | -1.2 K | -2.36 K | -6.58 K | -13.1 K | - | - |
EV/EBITDA |
0.7 | -3.9 | 0.8 | 0.3 | -0.3 | 0.4 | 0.2 | -0.6 | -1.6 | - | - | ||
PEG |
0.03 | 0.01 | 0.04 | -0.05 | -0.0 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | 0.02 | - | - |
P/B |
2.0 | 0.5 | 0.9 | 18.9 | 0.4 | 1.9 | -1.1 | 2.6 | 1.4 | 3.7 | 2.0 | - | - |
P/CF |
-1.2 | -0.9 | -2.2 | -5.1 | -0.2 | -0.4 | -0.5 | -0.7 | -0.5 | -1.4 | -2.6 | - | - |
ROE % |
-177.55 | -66.99 | -35.05 | -407.40 | -185.79 | -381.90 | 206.07 | -457.69 | -239.55 | -279.95 | -77.78 | - | - |
ROA % |
-83.53 | -48.17 | -29.13 | -127.16 | -90.83 | -114.79 | -483.87 | -84.65 | -102.28 | -134.53 | -59.48 | - | - |
ROCE % |
-190.20 | -69.33 | -35.77 | -256.00 | -141.07 | -245.46 | 515.05 | -181.31 | -151.34 | -171.92 | -65.62 | - | - |
Current Ratio |
1.9 | 3.6 | 5.9 | 2.0 | 2.8 | 2.1 | 0.5 | 2.3 | 3.0 | 4.6 | 10.1 | - | - |
DSO |
38.0 | 46.0 | 52.5 | - | 16.4 | 10.4 | 27.4 | 2.0 | 47.9 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
38.0 | 46.0 | 52.5 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
38.0 | 46.0 | 52.5 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Onconova Therapeutics
| 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-8.81 | -0.24 | - | -5.64 | -0.2 | -0.28 | - | -0.26 | -0.19 | -0.2 | - | -0.22 | -0.27 | -0.32 | - | -0.52 | -0.65 | -0.03 | - | -0.75 | -0.6 | -1.29 | - | -0.94 | -1.1 | -5.04 | - | -10.6 | -0.29 | -1.23 | - | -0.29 | -1.96 | -2.65 | - | -2.6 | -4.13 | -0.57 | -0.62 | -0.69 | -0.77 | -0.87 | -0.68 | -1.34 | -5.21 | -6.08 | -4.89 | -1.02 | -3.84 | -5.53 | - | - | - | - |
EBITDA per Share |
- | -0.25 | - | - | - | -0.29 | - | -0.27 | -0.2 | -0.2 | - | -0.25 | -0.29 | -0.28 | - | -0.52 | -0.63 | -0.03 | - | -0.83 | -0.61 | -1.23 | - | -0.98 | -1.38 | -5.83 | - | -10.2 | -0.67 | -1 | - | -0.78 | -1.95 | -2.74 | - | -2.55 | -4.08 | -0.57 | -0.62 | -0.67 | -0.76 | -0.86 | -0.68 | -1.28 | -4.74 | -5.71 | -4.47 | 3.29 | -3.69 | -4.93 | - | - | - | - |
ROE % |
268.74 | -170.62 | -80.38 | -96.55 | -80.09 | -68.05 | -36.38 | -43.33 | -34.11 | -36.48 | -32.47 | -133.54 | -227.65 | -334.59 | -303.29 | -227.22 | -50.09 | 148.00 | 649.19 | 549.91 | 374.57 | 213.00 | -277.00 | -217.46 | -58.64 | 46.70 | 152.99 | 115.78 | 19.02 | -128.31 | -330.93 | -389.60 | -411.06 | -375.29 | -271.44 | -330.31 | -337.04 | -321.23 | -280.03 | -239.34 | -199.45 | -141.43 | -77.78 | -53.12 | -26.69 | -6.39 | 12.07 | 5.59 | 4.68 | - | - | - | - | - |
ROA % |
-157.32 | -76.42 | -47.95 | -60.28 | -55.08 | -49.50 | -28.72 | -34.47 | -27.90 | -29.06 | -24.94 | -56.17 | -81.64 | -109.11 | -93.71 | -113.12 | -101.30 | -79.34 | -66.55 | -96.39 | -106.82 | -116.80 | -83.26 | -223.06 | -333.03 | -359.91 | -359.23 | -366.11 | -233.19 | -204.45 | -61.21 | -86.26 | -104.42 | -119.46 | -115.89 | -144.18 | -150.56 | -147.76 | -134.57 | -120.18 | -108.26 | -84.82 | -59.48 | -57.82 | -40.01 | -36.91 | -22.79 | -10.56 | -8.84 | - | - | - | - | - |
ROCE % |
263.11 | -181.16 | -86.28 | -103.18 | -85.03 | -71.34 | -37.38 | -45.41 | -36.54 | -39.92 | -33.14 | -134.75 | -228.32 | -333.09 | -303.45 | -219.06 | -33.07 | 165.70 | 635.73 | 531.88 | 343.65 | 159.06 | -318.08 | -260.27 | -98.61 | 57.98 | 167.82 | 67.40 | -90.83 | -268.39 | -401.07 | -459.78 | -418.07 | -381.91 | -271.56 | -330.28 | -337.02 | -321.23 | -280.22 | -239.60 | -199.15 | -141.09 | -77.38 | -52.76 | -32.13 | -11.33 | 7.31 | 0.80 | 5.17 | - | - | - | - | - |
Current Ratio |
0.8 | 1.5 | 1.9 | 2.2 | 2.6 | 2.9 | 3.6 | 4.2 | 5.0 | 5.6 | 5.9 | 5.8 | 3.9 | 4.2 | 1.4 | 1.4 | 1.4 | 1.4 | 2.0 | 2.0 | 2.0 | 2.0 | 1.4 | 1.4 | 1.4 | 1.4 | 0.3 | 0.3 | 0.3 | 0.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.9 | 1.9 | 1.9 | 1.9 | 2.0 | 2.0 | 2.0 | 2.0 | 4.3 | 4.3 | 4.3 | 4.3 | 2.0 | 2.0 | 2.0 | - | - | - | - | - |
DSO |
1712.1 | 29.3 | - | 28.0 | 27.2 | 37.5 | - | 44.8 | 44.0 | 44.8 | - | 44.8 | 52.0 | 61.1 | - | 51.2 | 60.3 | 118.5 | - | 141.9 | 4.4 | 89.2 | - | 26.6 | 6.6 | 7.6 | - | 48.9 | 16.6 | 19.6 | - | 1.7 | 1.3 | 47.5 | - | 84.6 | 1115.8 | 654.8 | 105.7 | 52.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
1712.1 | 29.3 | - | 28.0 | 27.2 | 37.5 | - | 44.8 | 44.0 | 44.8 | - | 44.8 | 52.0 | 61.1 | - | 51.2 | 60.3 | 118.5 | - | 141.9 | 4.4 | 89.2 | - | 26.6 | 6.6 | 7.6 | - | 48.9 | 16.6 | 19.6 | - | 1.7 | 1.3 | 47.5 | - | 84.6 | 1115.8 | 654.8 | 105.7 | 52.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
1712.1 | 29.3 | - | 28.0 | 27.2 | 37.5 | - | 44.8 | 44.0 | 44.8 | - | 44.8 | 52.0 | 61.1 | - | 51.2 | 60.3 | 118.5 | - | 141.9 | 4.4 | 89.2 | - | 26.6 | 6.6 | 7.6 | - | 48.9 | 16.6 | 19.6 | - | 1.7 | 1.3 | 47.5 | - | 84.6 | 1115.8 | 654.8 | 105.7 | 52.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency